Benefits of cannabidiol from Cannabis sativa on neurodegenerative illnesses: a review on its implementation in modern medicine

 

Tallennettuna:
Bibliografiset tiedot
Tekijät: Le-Roy-Caceres, Alessandra, Aguilera-Pogue, Mattias, Montero-Yee, Sofía, Soto-Pacheco, Helena, Ramírez-Hidalgo, Lucía, Aguilera Pogue, Mattias, Montero Yee, Sofía, Soto Pacheco, Helena, Ramírez Hidalgo, Lucía
Tila:Versión publicada
Julkaisupäivä:2026
Kuvaus:Cannabidiol is one of the most abundant compounds of Cannabis sativa, and it’s extremely important due to its high medical potential, especially in reference to neurodegenerative illnesses. Through physiological intervention carried out by the endocannabinoid system and its antioxidant properties, it's able to prevent phenomena such as neuronal apoptosis, and its able to assist with the management of the most prevalent symptoms, namely inflammation, pain and accumulation of toxic secondary compounds, of illnesses such as Alzheimer’s Disease, Parkinson’s Disease and Dementia. On the other hand, bioavailability, adverse effects, and personal beliefs correspond to factors that make the implementation of CBD in medications difficult. Finally, despite the fact that CBD presents ample benefits, it’s necessary to improve administration routes, the mitigation of unwanted side effects, and to change the social perception of the medical use of Cannabis sativa in order to allow the implementation of CBD as a regular treatment for neurodegenerative illnesses.
Maa:Portal de Revistas TEC
Organisaatio:Instituto Tecnológico de Costa Rica
Repositorio:Portal de Revistas TEC
Kieli:Español
OAI Identifier:oai:ojs.pkp.sfu.ca:article/8329
Linkit:https://revistas.tec.ac.cr/index.php/tec_marcha/article/view/8329
Sanahaku:Nervous system
Alzheimer’s Disease
Parkinson’s Disease
Dementia
Antioxidants
Endocannabinoid system
Sistema nervioso
Alzheimer
Parkinson
Demencia
Antioxidantes
Sistema de endocannabinoides